It is suggested that sNogo-B may take part in the pathogenesis of PD by down-regulating the expression of related proteins in the PI3K/Akt signaling pathway by inhibiting the Nogo-B/NgBR signal axis. This evidence concerns the gene AKT1 and Parkinson disease.